| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/23/2007 | WO2004017926A3 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 08/23/2007 | WO2004003176A9 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | WO2002018595A9 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 08/23/2007 | US20070199102 Isolated Nucleic Acid Molecules From The Genome Of Citrus Sudden Death Virus And Uses Thereof |
| 08/23/2007 | US20070199101 Nucleic Acid Molecules Encoding Cyclotide Polypeptides and Methods of Use |
| 08/23/2007 | US20070199083 Transgenic Nonhuman Mammal Representing The Pathologic Conditions Of Human Rheumatoid Arthritis |
| 08/23/2007 | US20070199080 Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disorders |
| 08/23/2007 | US20070199079 Monitoring APP cleavage in transgenic rodents comprising an APP swedish mutation |
| 08/23/2007 | US20070199078 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 08/23/2007 | US20070197778 having two or more maleimide groups and is a fluorescent labeling agent capable of switching fluorescence on and off by a reaction with a thiol group or a peptide or protein containing a cysteine residue; to introduce fluorescent tag of small molecular size into target protein at high sensitivity |
| 08/23/2007 | US20070197777 Cloning and expression of outer membrane protein C of salmonella typhi Ty2 and conjugation of the purified insoluble protein to VI-polysaccharide for use as a vaccine for typhoid fever |
| 08/23/2007 | US20070197776 Hydrogels for protein concentration |
| 08/23/2007 | US20070197775 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070197774 Adrenocorticotropic hormone analogs and related methods |
| 08/23/2007 | US20070197773 Methods and Systems for Generating and Evaluating Peptides |
| 08/23/2007 | US20070197771 cross metathesis; hydrogenation; stereoselective; synthesis of peptides with one or more intramolecular bridges |
| 08/23/2007 | US20070197443 Methods and Compositions for Modulating Immunity |
| 08/23/2007 | US20070197441 Truncated il-17ra soluble receptor and methods of using in inflammation |
| 08/23/2007 | US20070197440 Blood coagulation factor VIIa having a purity of at least 1000 IU/mg of protein; purified from human plasma; free of proteins of nonhuman origin |
| 08/23/2007 | US20070197438 cathepsin mediated diseases; proteinuria, cancer, and cognitive diseases; podocyte cell gene transfer |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070197431 Novel protein for inhibiting tumor progression and increasing nerve regeneration |
| 08/23/2007 | US20070197429 cyclic peptides having one or more of the bridged cysteine-amino acid residue pairs of the naturally occurring or native conotoxin substituted with amino acids bearing a dicarba- and disulfide-bridges; solid phase synthesis; metathesis |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070197426 Lactoferrin polypeptide, process for producing the same and inflammation inducing substance |
| 08/23/2007 | US20070196897 Polynucleotides encoding a novel human g-protein coupled receptor splice variant, hgprbmy29sv2 |
| 08/23/2007 | US20070196895 alternative media free from animal sources; Chinese hamster ovary (CHO) cells; Asparagine, Sodium Chloride, Selenite, Wheat hydrolysate and Insulin |
| 08/23/2007 | US20070196887 monitor a patient's response to glutamine supplementation undergoing radiation therapy; correlating the increase in the amount of serum proteins to the extent of protection of breast tissue against radiation injury |
| 08/23/2007 | US20070196886 Target And Method For Inhibition Of Bacterial Rna Polymerase Minimized Derivatives Of Peptide Antibiotic Mccj25 |
| 08/23/2007 | US20070196879 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 08/23/2007 | US20070196878 Immune diagnostic assay to diagnose and monitor tuberculosis infection |
| 08/23/2007 | US20070196873 Pain signaling molecules |
| 08/23/2007 | US20070196867 GPCR expressing cell lines and antibodies |
| 08/23/2007 | US20070196829 Screening for an antibacterial agent by contacting a test compound with an isolated Pseudomonas aeruginosa protein LpxC, determining whether the test compound binds to the protein, and determining whether the test compound has either bactericidal or bacteriostatic activity against Pseudomonas aeruginosa |
| 08/23/2007 | US20070196816 Engineered stimulus-responsive switches |
| 08/23/2007 | US20070196429 Proteins of natural origin and materials made therefrom |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196388 Cold-adapted equine influenza viruses |
| 08/23/2007 | US20070196387 Novel assay for the separation and quantification of hemagglutinin antigens |
| 08/23/2007 | US20070196378 Hyphae-Specific Cell Wall Proteins Of Candida |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196371 Soluble il-17rcx4 and methods of using in inflammation |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196352 Vegf-induced genes and their therapeutic use |
| 08/23/2007 | US20070196339 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/23/2007 | US20070196337 Recombinant perforin, expression and uses thereof |
| 08/23/2007 | US20070196334 Modified vectors for organelle transfection |
| 08/23/2007 | US20070196269 Pharmaceutical composition |
| 08/23/2007 | CA2836368A1 Selecting and stabilizing dsrna constructs |
| 08/23/2007 | CA2822302A1 Methods of impairing osteoclast differentiation |
| 08/23/2007 | CA2785046A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2642856A1 Apoptosis methods, genes and proteins |
| 08/23/2007 | CA2642056A1 Hpv antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2642054A1 Influenza antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2641996A1 Plant chimeric binding polypeptides for universal molecular recognition |
| 08/23/2007 | CA2641342A1 Long-acting polypeptides and methods of producing and administering same |
| 08/23/2007 | CA2639115A1 Molecules and methods of using same for treating ccr5/ccr5 ligands associated diseases |
| 08/23/2007 | CA2638907A1 Rage fusion proteins and methods of use |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2637665A1 Identification and use of target genes for control of plant parasitic nematodes |
| 08/23/2007 | CA2636890A1 Zmtcrr-1 plant signal transduction gene and promoter |
| 08/23/2007 | CA2633005A1 Dengue chimeric viruses |
| 08/23/2007 | CA2630928A1 Novel cc-chemokine antagonists |
| 08/22/2007 | EP1820862A2 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820860A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820858A1 Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1820853A2 Recombinant influenza viruses for vaccines and gene therapy |
| 08/22/2007 | EP1820846A1 Cell culture system |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820508A1 Coagulation factor X polypeptides with modified activation properties |
| 08/22/2007 | EP1819831A2 P1-34 expression units with corynebacterium glutamicum |
| 08/22/2007 | EP1819820A1 Protein isolation and purification |
| 08/22/2007 | EP1819818A1 Aspergillus niger promoter for expressing genes in host cells |
| 08/22/2007 | EP1819814A2 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 08/22/2007 | EP1819729A2 Method for producing carboxy-terminal amidified peptides |
| 08/22/2007 | EP1819728A2 Il-7 variants with reduced immunogenicity |
| 08/22/2007 | EP1819727A2 Treatement of disease |
| 08/22/2007 | EP1819726A1 Modulation of ovulation |
| 08/22/2007 | EP1819725A1 Production of proteins |
| 08/22/2007 | EP1819724A1 Compositions containing beta 2-glycoprotein i for the prevention and/or treatment of vascular disease |
| 08/22/2007 | EP1819722A1 Modulation of ovulation |
| 08/22/2007 | EP1819354A2 Methods and compounds for treating diabetes |
| 08/22/2007 | EP1727830A4 Mussel bioadhesive |
| 08/22/2007 | EP1720904A4 Treating or preventing extracellular matrix build-up |
| 08/22/2007 | EP1711592A4 Cell cycle genes and related methods of using |
| 08/22/2007 | EP1660654A4 Expression vector |
| 08/22/2007 | EP1641422A4 Interleukin-21 analogs |
| 08/22/2007 | EP1631586B1 Peptide analogues comprising at least one type of aminoacyl aza-beta 3 and the use thereof, in particular for therapy |
| 08/22/2007 | EP1608678B1 Process for isolating haemocyanin |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1572732B1 Isolated fluorescent protein from clytia gregaria cgfp and use thereof |
| 08/22/2007 | EP1553979B1 Ihnv g fusion protein for immune stimulation |
| 08/22/2007 | EP1546202B1 Human coagulation factor vii polypeptides |
| 08/22/2007 | EP1534829A4 Plant defensins |
| 08/22/2007 | EP1501542B1 Improved polysaccharide and glycoconjugate vaccines |